BioSpace News Archive

Year

• 2005
• 2006
• 2007
• 2008
• 2009
• 2010
• 2011
• 2012
• 2013
• 2014
• 2015
• 2016
• 2017
• 2018
• 2019
• 2020
• 2021
• 2022
• 2023
• 2024
• 2025
• 2026

Month

• January
• February
• March
• April
• May
• June
• July
• August
• September
• October
• November
• December

Day

• 2
• 3
• 4
• 5
• 6
• 9
• 10
• 11
• 12
• 13
• 14
• 15
• 16
• 17
• 18
• 19
• 20
• 21
• 23
• 24
• 25
• 26
• 27
• 28
• 29
• 30
• 31

• Genetown

  Centrexion Therapeutics Announces Multiple Data Presentations on CNTX-4975 at the American College of Rheumatology Annual Meeting 2017

  The presentations include 6-month data from the Phase 2b TRIUMPH study assessing the efficacy and safety of CNTX-4975.

  October 30, 2017

   · 

  3 min read
• Drug Development

  Vaxart Announces Positive Safety and Immunogenicity Results for Its Oral Norovirus Vaccine in A Phase 1b Clinical Study

  The norovirus tablet vaccine was generally well tolerated in all subjects. Adverse events (AEs) were mostly mild in severity with headache as the most frequent AE.

  October 30, 2017

   · 

  7 min read
• Business

  Regen BioPharma Announces Former Eli Lilly Executive and Current CVS Board Member will Lead Newly Formed Business Advisory Board

  Regen BioPharma announced that former Eli Lilly executive Jean-Pierre Millon will serve as chairman of its newly formed business advisory board.

  October 30, 2017

   · 

  4 min read
• Business

  AMRI Appoints Paul Feuerman as Senior VP, General Counsel and Head of Business Development

  AMRI today announced that Paul Feuerman has joined the company as senior VP, general counsel and head of business development and will be responsible for leading all AMRI’s legal, M&A, and corporate affairs activities for the company’s locations worldwide.

  October 30, 2017

   · 

  2 min read
• 

  FDA

  FDA Approves Janssen’s New 10 Mg Dosing for XARELTO (Rivaroxaban) to Reduce the Continued Risk of Venous Thromboembolism

  The study shows XARELTO 10 mg reduced the risk of recurrent VTE by 74 percent.

  October 30, 2017

   · 

  16 min read
• Business

  TELA Bio Announces Hiring of Greg Firestone as VP of Strategic Customer Relations

  TELA Bio today announced that Greg Firestone has joined the company as VP of strategic customer relations and will be responsible for developing collaborative relationships.

  October 30, 2017

   · 

  3 min read
• FDA

  Allergan Receives Approval for Ozurdex (Dexamethasone Intravitreal Implant 0.7 mg) in China for the Treatment of Retinal Vein Occlusion (RVO)

  Ozurdex is the first approved intravitreal injection for RVO in China.

  October 30, 2017

   · 

  7 min read
• Business

  Castle Creek Pharma Announces Hiring of Dr. Amir Tavakkol as Executive VP and Chief Development Officer

  Castle Creek Pharma today announced that Amir Tavakkol, Ph.D., has joined the company as executive VP and chief development officer who will report directly to Michael Derby, co-founder and CEO at CCP.

  October 30, 2017

   · 

  2 min read
• Business

  Daiichi Sankyo Working with Berkeley Lights’ Beacon OptoFluidic Platform for Cell Line Development

  Berkeley Lights announced today a program with Daiichi Sankyo focused on using the Beacon platform to accelerate its cell line development workflow.

  October 30, 2017

   · 

  2 min read
• Business

  Medizone’s AsepticSure Disinfection System Introduced to Nordic Region

  Medizone and Aglon a/s today announced that they have entered into an agreement for the introduction and distribution of AsepticSure in the Nordic Region.

  October 30, 2017

   · 

  3 min read